References
- Bayat M , AbbasiAJ , NoorbalaAA , MohebbiSZ , MoharramiM , YekaninejadMS. Oral health-related quality of life in patients with temporomandibular disorders: a case-control study considering psychological aspects. Int. J. Dent. Hyg.16(1), 165–170 (2018).
- Manfredini D , WinocurE , AhlbergJ , Guarda-NardiniL , LobbezooF. Psychosocial impairment in temporomandibular disorders patients. RDC/TMD axis II findings from a multicentre study. J. Dent.38(10), 765–772 (2010).
- Balik A , PekerK , Ozdemir-KaratasM. Comparisons of measures that evaluate oral and general health quality of life in patients with temporomandibular disorder and chronic pain. Cranio1–11 (2019) ( Epub ahead of print).
- Bitiniene D , ZamaliauskieneR , KubiliusR , LeketasM , GailiusT , SmirnovaiteK. Quality of life in patients with temporomandibular disorders. A systematic review. Stomatologija20(1), 3–9 (2018).
- Dahlstrom L , CarlssonGE. Temporomandibular disorders and oral health-related quality of life. A systematic review. Acta Odontol. Scand.68(2), 80–85 (2010).
- Schierz O , JohnMT , ReissmannDR , MehrstedtM , SzentpeteryA. Comparison of perceived oral health in patients with temporomandibular disorders and dental anxiety using oral health-related quality of life profiles. Qual. Life Res.17(6), 857–866 (2008).
- Dalewski B , KaminskaA , SzydlowskiM , KozakM , SobolewskaE. Comparison of early effectiveness of three different intervention methods in patients with chronic orofacial pain: a randomized, controlled clinical trial. Pain Res. Manag.2019, 7954291 (2019).
- Schiffman E , OhrbachR , TrueloveE , LookJ , AndersonG , GouletJPet al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group. J. Oral Facial Pain Headache28(1), 6–27 (2014).
- Costa YM , PorporattiAL , Stuginski-BarbosaJ , BonjardimLR , ContiPC. Additional effect of occlusal splints on the improvement of psychological aspects in temporomandibular disorder subjects: a randomized controlled trial. Arch. Oral Biol.60(5), 738–744 (2015).
- Machado D , MartimbiancoALC , BussadoriSK , PachecoRL , RieraR , SantosEM. Botulinum toxin Type A for painful temporomandibular disorders: systematic review and meta-analysis. J. Pain21(3-4). 281–293 (2020).
- De la Torre Canales G , Camara-SouzaMB , do AmaralCF , GarciaRC , ManfrediniD. Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review. Clin. Oral Investig.21(3), 727–734 (2017).
- Soares A , AndrioloRB , AtallahAN , da SilvaEM. Botulinum toxin for myofascial pain syndromes in adults. Cochrane Database Syst. Rev.7, CD007533 (2014).
- Villa S , RaoulG , MachuronF , FerriJ , NicotR. Improvement in quality of life after botulinum toxin injection for temporomandibular disorder. J. Stomatol. Oral Maxillofac. Surg.120(1), 2–6 (2019).
- Slade GD , SpencerAJ. Development and evaluation of the oral health impact profile. Community Dent. Health11(1), 3–11 (1994).
- Goncalves DA , DalFabbro AL , CamposJA , BigalME , SpecialiJG. Symptoms of temporomandibular disorders in the population: an epidemiological study. J. Orofac. Pain24(3), 270–278 (2010).
- Behzadi F , MandellJC , SmithSE , GuenetteJP. Temporomandibular joint imaging: current clinical applications, biochemical comparison with the intervertebral disc and knee meniscus, and opportunities for advancement. Skeletal Radiol.49(8), 1183–1193 (2020).
- de Freitas RF , FerreiraMA , BarbosaGA , CalderonPS. Counselling and self-management therapies for temporomandibular disorders: a systematic review. J. Oral Rehabil.40(11), 864–874 (2013).
- Carlsson GE . Some dogmas related to prosthodontics, temporomandibular disorders and occlusion. Acta Odontol. Scand.68(6), 313–322 (2010).
- Saha FJ , PullaA , OstermannT , MillerT , DobosG , CramerH. Effects of occlusal splint therapy in patients with migraine or tension-type headache and comorbid temporomandibular disorder: a randomized controlled trial. Medicine (Baltimore)98(33), e16805 (2019).
- Fricton J , LookJO , WrightEet al. Systematic review and meta-analysis of randomized controlled trials evaluating intraoral orthopedic appliances for temporomandibular disorders. J. Orofac. Pain24(3), 237–254 (2010).
- Ahmad M , SchiffmanEL. Temporomandibular joint disorders and orofacial pain. Dent. Clin. North Am.60(1), 105–124 (2016).
- Miller J , ClarksonE. Botulinum toxin Type A: review and its role in the dental office. Dent. Clin. North Am.60(2), 509–521 (2016).
- Borodic GE , AcquadroM , JohnsonEA. Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opin. Investig. Drugs10(8), 1531–1544 (2001).
- Smith HS , AudetteJ , RoyalMA. Botulinum toxin in pain management of soft tissue syndromes. Clin. J. Pain18(Suppl. 6), S147–S154 (2002).
- Venancio Rde A , AlencarFGJr , ZamperiniC. Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches. Cranio27(1), 46–53 (2009).
- Kamanli A , KayaA , ArdicogluO , OzgocmenS , ZenginFO , BayikY. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol. Int.25(8), 604–611 (2005).
- Al-Wayli H . Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study. J. Clin. Exp. Dent.9(1), e112–e117 (2017).
- Lobbezoo F , AhlbergJ , RaphaelKGet al. International consensus on the assessment of bruxism: report of a work in progress. J. Oral Rehabil.45(11), 837–844 (2018).
- Slade GD . Derivation and validation of a short-form oral health impact profile. Community Dent. Oral Epidemiol.25(4), 284–290 (1997).